J Korean Neurosurg Soc.  2015 May;57(5):315-322. 10.3340/jkns.2015.57.5.315.

Understanding the Treatment Strategies of Intracranial Germ Cell Tumors: Focusing on Radiotherapy

• Kim JY
• Park J

• KMID: 1881727
• DOI: http://doi.org/10.3340/jkns.2015.57.5.315

Abstract

Intracranial germ cell tumors (ICGCT) occur in 2-11% of children with brain tumors between 0-19 years of age. For treatment of germinoma, relatively low radiation doses with or without chemotherapy show excellent 10 year survival rate of 80-100%. Past studies showed that neoadjuvant chemotherapy combined with focal radiotherapy resulted in unacceptably high rates of periventricular tumor recurrence. The use of generous radiation volume which covers the whole ventricular space with later boost treatment to primary site is considered as standard treatment of intracranial germinomas. For non-germinomatous germ cell tumors (NGGCT), 10-year overall survival rate is still much inferior than that of intracranial germinoma despite intensive chemotherapy and high-dose radiotherapy. Craniospinal radiotherapy combined with cisplatin-based chemotherapy provides the best treatment outcome for NGGCT; 60-70% of overall survival rate. There is a debate on the surgical role whether surgery can contribute to improved treatment outcome of NGGCT when added to combined chemoradiotherapy. Because higher dose of radiotherapy is required for treatment of NGGCT than for germinoma, it is tested whether whole ventricular irradiation can replace craniospinal irradiation in intermediate risk group of NGGCT to minimize radiation-related late toxicity in the recent studies. To minimize the treatment-related neural deficit and late sequelae while maintaining long-term survival rate of ICGCT patients, optimized administration of chemotherapy and radiotherapy should be selected. Use of technically upgraded radiotherapy modalities such as intensity-modulated radiotherapy or proton beam therapy is expected to bring an improved neurocognitive outcome with longitudinal assessment of the patients.

Keyword

Intracranial germ cell tumor; ICGCT; Radiotherapy; Proton beam therapy; Biology

MeSH Terms

Biology
Brain Neoplasms
Chemoradiotherapy
Child
Craniospinal Irradiation
Drug Therapy
Germinoma
Humans
Neoplasms, Germ Cell and Embryonal*
Proton Therapy
Radiotherapy*
Radiotherapy, Intensity-Modulated
Recurrence
Survival Rate
Treatment Outcome

Figure

• 

  Fig. 1 Unusual sites of germ cell tumors in the brain. A : T2-axial (left) and T2-sagittal (right) magnetic resonance images show a nodular mass (arrow) in the posterior aspect of medulla. B : Pre-treatment images of a subtle patch streaky lesion involving the right internal capsule. Left : T2 image, Right : nodular contrast enhancement of the right basal ganglia. C : A solid and cystic mass in the right lenticular nucleus area before treatment (left) and 5 years after radiotherapy (right). D : Germinoma of the left basal ganglia. Subtle patchy lesion visible mainly in T2-weighted and fluid-attenuated inversion recovery images with no contrast enhancement in the left basal ganglia before treatment (left) and 2 years after treatment (right). The biopsy site is seen at the left basal ganglia in both scans. E : A huge mass in right basal ganglia with mass effect. The mass did not show any contrast enhancement before treatment (left) or 2 years after treatment (right). F : Huge germinoma involving bilateral basal ganglia, which shows contrast enhancement and peritumor edema. Top left and top right : pre-treatment axial T2 and coronal T1 images with contrast enhancement, Bottom left : axial T2 image 3 years after proton beam therapy, Bottom right : coronal T1 image with contrast enhancement. Magnetic resonance imaging 3 years after treatment shows a residual cystic lesion in the right basal ganglia, with white matter changes in the left frontal periventricular area.

• 

  Fig. 2 Sample treatment plan for craniospinal irradiation showing dose distributions. A : Sagittal view of 3-dimensional conformal radiation therapy (3D-CRT). B : Axial view of 3D-CRT. C : Sagittal view of proton beam treatment (PBT). D : Axial view of PBT. Yoon M, Shin DH, Kim J, Kim JW, Kim DW, Park SY, et al. Int J Radiat Oncol Biol Phys 81 : 637-646, 201169) with permission.

• 

  Fig. 3 A : Radiation dose distribution for whole ventricle (WV) irradiation. Comparison of 3D-conformal radiotherapy (3D-CRT), intensity-modulated radiotherapy (IMRT) passive scattering proton beam therapy (PS-PBT), and spot scanning proton beam therapy (SS-PBT). Thick pink lines are planning target volume (PTV) for the WV. The blue, green, and yellow lines represent the 10 Gy, 15 Gy, and 29.1 Gy isodose lines, respectively. B : Dose-volume histogram of the normal brain and both temporal lobes for WV irradiation, including the pineal gland tumor bed. The prescribed (100%) doses are 30.6 Gy for 95% volume of the WV PTV.

• 

  Fig. 4 Dose distribution of primary site irradiation to tumors arising in the pineal gland (A), suprasellar (B), and basal ganglia (C), with their pre-chemotherapy magnetic resonance imaging. The thick red lines represent planning target volumes (PTV) to the primary tumor sites. The thick blue and green lines represent 10 Gy and 15 Gy isodose lines, respectively. The prescribed doses are 30.6 Gy at 95% volume of the PTV.

Reference

1. Aizer AA, Sethi RV, Hedley-Whyte ET, Ebb D, Tarbell NJ, Yock TI, et al. Bifocal intracranial tumors of nongerminomatous germ cell etiology : diagnostic and therapeutic implications. Neuro Oncol. 2013; 15:955–960. PMID: 23640532.

2. Alapetite C, Brisse H, Patte C, Raquin MA, Gaboriaud G, Carrie C, et al. Pattern of relapse and outcome of non-metastatic germinoma patients treated with chemotherapy and limited field radiation : the SFOP experience. Neuro Oncol. 2010; 12:1318–1325. PMID: 20716594.

3. Allen J, Chacko J, Donahue B, Dhall G, Kretschmar C, Jakacki R, et al. Diagnostic sensitivity of serum and lumbar CSF bHCG in newly diagnosed CNS germinoma. Pediatr Blood Cancer. 2012; 59:1180–1182. PMID: 22302772.

4. Aoyama H, Shirato H, Ikeda J, Fujieda K, Miyasaka K, Sawamura Y. Induction chemotherapy followed by low-dose involved-field radiotherapy for intracranial germ cell tumors. J Clin Oncol. 2002; 20:857–865. PMID: 11821471.

5. Armstrong GT, Jain N, Liu W, Merchant TE, Stovall M, Srivastava DK, et al. Region-specific radiotherapy and neuropsychological outcomes in adult survivors of childhood CNS malignancies. Neuro Oncol. 2010; 12:1173–1186. PMID: 20716593.

6. Arora RS, Alston RD, Eden TO, Estlin EJ, Moran A, Birch JM. Age-incidence patterns of primary CNS tumors in children, adolescents, and adults in England. Neuro Oncol. 2009; 11:403–413. PMID: 19033157.

7. Barney CL, Brown AP, Grosshans DR, McAleer MF, de Groot JF, Puduvalli V, et al. Technique, outcomes, and acute toxicities in adults treated with proton beam craniospinal irradiation. Neuro Oncol. 2014; 16:303–309. PMID: 24311638.

8. Brown AP, Barney CL, Grosshans DR, McAleer MF, de Groot JF, Puduvalli VK, et al. Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma. Int J Radiat Oncol Biol Phys. 2013; 86:277–284. PMID: 23433794.

9. Calaminus G, Kortmann R, Worch J, Nicholson JC, Alapetite C, Garrè ML, et al. SIOP CNS GCT 96 : final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease. Neuro Oncol. 2013; 15:788–796. PMID: 23460321.

10. Chen MJ, Santos Ada S, Sakuraba RK, Lopes CP, Gonçalves VD, Weltman E, et al. Intensity-modulated and 3D-conformal radiotherapy for whole-ventricular irradiation as compared with conventional whole-brain irradiation in the management of localized central nervous system germ cell tumors. Int J Radiat Oncol Biol Phys. 2010; 76:608–614. PMID: 19879065.

11. Chen YW, Huang PI, Ho DM, Hu YW, Chang KP, Chiou SH, et al. Change in treatment strategy for intracranial germinoma : long-term follow-up experience at a single institute. Cancer. 2012; 118:2752–2762. PMID: 21989828.

12. Cheng L, Sung MT, Cossu-Rocca P, Jones TD, MacLennan GT, De Jong J, et al. OCT4 : biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol. 2007; 211:1–9. PMID: 17117392.

13. Cho J, Choi JU, Kim DS, Suh CO. Low-dose craniospinal irradiation as a definitive treatment for intracranial germinoma. Radiother Oncol. 2009; 91:75–79. PMID: 19019472.

14. Committee of Brain Tumor Registry of Japan. Report of Brain Tumor Registry of Japan (1969-1996). Neurol Med Chir (Tokyo). 2003; 43(Suppl):i–vii. 1–111. PMID: 14705327.

15. Eom KY, Kim IH, Park CI, Kim HJ, Kim JH, Kim K, et al. Upfront chemotherapy and involved-field radiotherapy results in more relapses than extended radiotherapy for intracranial germinomas : modification in radiotherapy volume might be needed. Int J Radiat Oncol Biol Phys. 2008; 71:667–671. PMID: 18514777.

16. Fritsch MK, Schneider DT, Schuster AE, Murdoch FE, Perlman EJ. Activation of Wnt/beta-catenin signaling in distinct histologic subtypes of human germ cell tumors. Pediatr Dev Pathol. 2006; 9:115–131. PMID: 16822086.

17. Fukushima S, Otsuka A, Suzuki T, Yanagisawa T, Mishima K, Mukasa A, et al. Mutually exclusive mutations of KIT and RAS are associated with KIT mRNA expression and chromosomal instability in primary intracranial pure germinomas. Acta Neuropathol. 2014; 127:911–925. PMID: 24452629.

18. Furukawa S, Haruta M, Arai Y, Honda S, Ohshima J, Sugawara W, et al. Yolk sac tumor but not seminoma or teratoma is associated with abnormal epigenetic reprogramming pathway and shows frequent hypermethylation of various tumor suppressor genes. Cancer Sci. 2009; 100:698–708. PMID: 19245437.

19. Gillis AJ, Stoop HJ, Hersmus R, Oosterhuis JW, Sun Y, Chen C, et al. High-throughput microRNAome analysis in human germ cell tumours. J Pathol. 2007; 213:319–328. PMID: 17893849.

20. Glenn OA, Barkovich AJ. Intracranial germ cell tumors : a comprehensive review of proposed embryologic derivation. Pediatr Neurosurg. 1996; 24:242–251. PMID: 8933567.

21. Hardenbergh PH, Golden J, Billet A, Scott RM, Shrieve DC, Silver B, et al. Intracranial germinoma : the case for lower dose radiation therapy. Int J Radiat Oncol Biol Phys. 1997; 39:419–426. PMID: 9308946.

22. Hattab EM, Tu PH, Wilson JD, Cheng L. OCT4 immunohistochemistry is superior to placental alkaline phosphatase (PLAP) in the diagnosis of central nervous system germinoma. Am J Surg Pathol. 2005; 29:368–371. PMID: 15725806.

23. Jensen AW, Laack NN, Buckner JC, Schomberg PJ, Wetmore CJ, Brown PD. Long-term follow-up of dose-adapted and reduced-field radiotherapy with or without chemotherapy for central nervous system germinoma. Int J Radiat Oncol Biol Phys. 2010; 77:1449–1456. PMID: 20045266.

24. Jinguji S, Yoshimura J, Nishiyama K, Aoki H, Nagasaki K, Natsumeda M, et al. Factors affecting functional outcomes in long-term survivors of intracranial germinomas : a 20-year experience in a single institution. J Neurosurg Pediatr. 2013; 11:454–463. PMID: 23373627.

25. Kamoshima Y, Sawamura Y, Ikeda J, Shirato H, Aoyama H. Late recurrence and salvage therapy of CNS germinomas. J Neurooncol. 2008; 90:205–211. PMID: 18604473.

26. Kawabata Y, Takahashi JA, Arakawa Y, Shirahata M, Hashimoto N. Long term outcomes in patients with intracranial germinomas : a single institution experience of irradiation with or without chemotherapy. J Neurooncol. 2008; 88:161–167. PMID: 18286232.

27. Kim JW, Kim WC, Cho JH, Kim DS, Shim KW, Lyu CJ, et al. A multimodal approach including craniospinal irradiation improves the treatment outcome of high-risk intracranial nongerminomatous germ cell tumors. Int J Radiat Oncol Biol Phys. 2012; 84:625–631. PMID: 22420971.

28. Kim JY. The Treatment Result of Intracranial Germ Cell Tumors in Korea; KSPNO G081 Multicenter trial, KSPNO-G052/082 Trial : New Horizon of the Germ Cell Therapy. Seoul: The Korean Society for Pediatric Neuro-Oncology;2013. p. 42. p. 49.

29. Kun LE, MacDonald S, Tarbell NJ. Supratentorial Brain Tumors. In : Halperin EC, Constine LS, Tarbell NJ, Kun LE, editors. Pediatric Radiation Oncology. Philadelphia: Lippincott Williams & Wilkins;2011. p. 44.

30. Lee CH, Jung KW, Yoo H, Park S, Lee SH. Epidemiology of primary brain and central nervous system tumors in Korea. J Korean Neurosurg Soc. 2010; 48:145–152. PMID: 20856664.

31. Mabbott DJ, Monsalves E, Spiegler BJ, Bartels U, Janzen L, Guger S, et al. Longitudinal evaluation of neurocognitive function after treatment for central nervous system germ cell tumors in childhood. Cancer. 2011; 117:5402–5411. PMID: 21563173.

32. Maity A, Shu HK, Janss A, Belasco JB, Rorke L, Phillips PC, et al. Craniospinal radiation in the treatment of biopsy-proven intracranial germinomas : twenty-five years' experience in a single center. Int J Radiat Oncol Biol Phys. 2004; 58:1165–1170. PMID: 15001260.

33. Matsutani M. Treatment of intracranial Germ Cell Tumor in Japan : New Horizon of the Germ Cell Therapy. Seoul: The Korean Society for Pediatric Neuro-Oncology;2013. p. 8.

34. Matsutani M. Japanese Pediatric Brain Tumor Study Group. Combined chemotherapy and radiation therapy for CNS germ cell tumors--the Japanese experience. J Neurooncol. 2001; 54:311–316. PMID: 11767296.

35. Matsutani M, Sano K, Takakura K, Fujimaki T, Nakamura O, Funata N, et al. Primary intracranial germ cell tumors : a clinical analysis of 153 histologically verified cases. J Neurosurg. 1997; 86:446–455. PMID: 9046301.

36. Merchant TE, Kiehna EN, Li C, Shukla H, Sengupta S, Xiong X, et al. Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma. Int J Radiat Oncol Biol Phys. 2006; 65:210–221. PMID: 16472938.

37. Merchant TE, Sherwood SH, Mulhern RK, Rose SR, Thompson SJ, Sanford RA, et al. CNS germinoma : disease control and long-term functional outcome for 12 children treated with craniospinal irradiation. Int J Radiat Oncol Biol Phys. 2000; 46:1171–1176. PMID: 10725628.

38. Miralbell R, Lomax A, Cella L, Schneider U. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys. 2002; 54:824–829. PMID: 12377335.

39. Murray MJ, Halsall DJ, Hook CE, Williams DM, Nicholson JC, Coleman N. Identification of microRNAs From the miR-371~373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumors. Am J Clin Pathol. 2011; 135:119–125. PMID: 21173133.

40. Nguyen QN, Chang EL, Allen PK, Maor MH, Ater JL, Mahajan A, et al. Focal and craniospinal irradiation for patients with intracranial germinoma and patterns of failure. Cancer. 2006; 107:2228–2236. PMID: 17019739.

41. Odagiri K, Omura M, Hata M, Aida N, Niwa T, Ogino I, et al. Treatment outcomes, growth height, and neuroendocrine functions in patients with intracranial germ cell tumors treated with chemoradiation therapy. Int J Radiat Oncol Biol Phys. 2012; 84:632–638. PMID: 22420962.

42. Ogawa K, Shikama N, Toita T, Nakamura K, Uno T, Onishi H, et al. Long-term results of radiotherapy for intracranial germinoma : a multi-institutional retrospective review of 126 patients. Int J Radiat Oncol Biol Phys. 2004; 58:705–713. PMID: 14967424.

43. Ogino H, Shibamoto Y, Takanaka T, Suzuki K, Ishihara S, Yamada T, et al. CNS germinoma with elevated serum human chorionic gonadotropin level : clinical characteristics and treatment outcome. Int J Radiat Oncol Biol Phys. 2005; 62:803–808. PMID: 15936563.

44. Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y, et al. CBTRUS statistical report : primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol. 2013; 15(Suppl 2):ii1–ii56. PMID: 24137015.

45. Palmer RD, Murray MJ, Saini HK, van Dongen S, Abreu-Goodger C, Muralidhar B, et al. Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets. Cancer Res. 2010; 70:2911–2923. PMID: 20332240.

46. Paximadis P, Hallock A, Bhambhani K, Chu R, Sood S, Wang Z, et al. Patterns of failure in patients with primary intracranial germinoma treated with neoadjuvant chemotherapy and radiotherapy. Pediatr Neurol. 2012; 47:162–166. PMID: 22883279.

47. Phi JH, Cho BK, Kim SK, Paeng JC, Kim IO, Kim IH, et al. Germinomas in the basal ganglia : magnetic resonance imaging classification and the prognosis. J Neurooncol. 2010; 99:227–236. PMID: 20087754.

48. Phi JH, Kim SK, Lee J, Park CK, Kim IH, Ahn HS, et al. The enigma of bifocal germ cell tumors in the suprasellar and pineal regions : synchronous lesions or metastasis? J Neurosurg Pediatr. 2013; 11:107–114. PMID: 23198842.

49. Report of Brain Tumor Registry of Japan (1984-2000). Neurol Med Chir (Tokyo). 2009; 49:PS1–PS96. PMID: 23914398.

50. Robertson PL, DaRosso RC, Allen JC. Improved prognosis of intracranial non-germinoma germ cell tumors with multimodality therapy. J Neurooncol. 1997; 32:71–80. PMID: 9049865.

51. Sawamura Y, Ikeda J, Shirato H, Tada M, Abe H. Germ cell tumours of the central nervous system : treatment consideration based on 111 cases and their long-term clinical outcomes. Eur J Cancer. 1998; 34:104–110. PMID: 9624246.

52. Schneider DT, Schuster AE, Fritsch MK, Hu J, Olson T, Lauer S, et al. Multipoint imprinting analysis indicates a common precursor cell for gonadal and nongonadal pediatric germ cell tumors. Cancer Res. 2001; 61:7268–7276. PMID: 11585765.

53. Shibamoto Y. Management of central nervous system germinoma : proposal for a modern strategy. Prog Neurol Surg. 2009; 23:119–129. PMID: 19329866.

54. Shibamoto Y, Sasai K, Oya N, Hiraoka M. Intracranial germinoma : radiation therapy with tumor volume-based dose selection. Radiology. 2001; 218:452–456. PMID: 11161161.

55. Shim KW, Kim TG, Suh CO, Cho JH, Yoo CJ, Choi JU, et al. Treatment failure in intracranial primary germinomas. Childs Nerv Syst. 2007; 23:1155–1161. PMID: 17610071.

56. Shim KW, Park EK, Lee YH, Suh CO, Cho J, Choi JU, et al. Treatment strategy for intracranial primary pure germinoma. Childs Nerv Syst. 2013; 29:239–248. PMID: 22965772.

57. Sievers S, Alemazkour K, Zahn S, Perlman EJ, Gillis AJ, Looijenga LH, et al. IGF2/H19 imprinting analysis of human germ cell tumors (GCTs) using the methylation-sensitive single-nucleotide primer extension method reflects the origin of GCTs in different stages of primordial germ cell development. Genes Chromosomes Cancer. 2005; 44:256–264. PMID: 16001432.

58. Song S, Park HJ, Yoon JH, Kim DW, Park J, Shin D, et al. Proton beam therapy reduces the incidence of acute haematological and gastrointestinal toxicities associated with craniospinal irradiation in pediatric brain tumors. Acta Oncol. 2014; 53:1158–1164. PMID: 24913151.

59. Terashima K, Yu A, Chow WY, Hsu WC, Chen P, Wong S, et al. Genome-wide analysis of DNA copy number alterations and loss of heterozygosity in intracranial germ cell tumors. Pediatr Blood Cancer. 2014; 61:593–600. PMID: 24249158.

60. Uematsu Y, Tsuura Y, Miyamoto K, Itakura T, Hayashi S, Komai N. The recurrence of primary intracranial germinomas. Special reference to germinoma with STGC (syncytiotrophoblastic giant cell). J Neurooncol. 1992; 13:247–256. PMID: 1517802.

61. Villani A, Bouffet E, Blaser S, Millar BA, Hawkins C, Bartels U. Inherent diagnostic and treatment challenges in germinoma of the basal ganglia : a case report and review of the literature. J Neurooncol. 2008; 88:309–314. PMID: 18365143.

62. Wang HW, Wu YH, Hsieh JY, Liang ML, Chao ME, Liu DJ, et al. Pediatric primary central nervous system germ cell tumors of different prognosis groups show characteristic miRNome traits and chromosome copy number variations. BMC Genomics. 2010; 11:132. PMID: 20178649.

63. Wang L, Yamaguchi S, Burstein MD, Terashima K, Chang K, Ng HK, et al. Novel somatic and germline mutations in intracranial germ cell tumours. Nature. 2014; 511:241–245. PMID: 24896186.

64. Weksberg DC, Shibamoto Y, Paulino AC. Bifocal intracranial germinoma : a retrospective analysis of treatment outcomes in 20 patients and review of the literature. Int J Radiat Oncol Biol Phys. 2012; 82:1341–1351. PMID: 21669501.

65. Wöhrer A, Waldhör T, Heinzl H, Hackl M, Feichtinger J, Gruber-Mösenbacher U, et al. The Austrian Brain Tumour Registry : a cooperative way to establish a population-based brain tumour registry. J Neurooncol. 2009; 95:401–411. PMID: 19562257.

66. Wong TT, Chen YW, Guo WY, Chang KP, Ho DM, Yen SH. Germinoma involving the basal ganglia in children. Childs Nerv Syst. 2008; 24:71–78. PMID: 17906866.

67. Wong TT, Ho DM, Chang KP, Yen SH, Guo WY, Chang FC, et al. Primary pediatric brain tumors : statistics of Taipei VGH, Taiwan (1975-2004). Cancer. 2005; 104:2156–2167. PMID: 16220552.

68. Yen SH, Chen YW, Huang PI, Wong TT, Ho DM, Chang KP, et al. Optimal treatment for intracranial germinoma : can we lower radiation dose without chemotherapy? Int J Radiat Oncol Biol Phys. 2010; 77:980–987. PMID: 19864081.

69. Yoon M, Shin DH, Kim J, Kim JW, Kim DW, Park SY, et al. Craniospinal irradiation techniques : a dosimetric comparison of proton beams with standard and advanced photon radiotherapy. Int J Radiat Oncol Biol Phys. 2011; 81:637–646. PMID: 20932690.